Dr. Saranya Chumsri, MD

Dr. Chumsri practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Chumsri's NPI, 1508908328, was assigned on February 12, 2007. Dr. Chumsri graduated from Chulalongkorn University Faculty of Medicine in 1999. Dr. Chumsri holds Florida license ME120223.

Dr. Chumsri's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Chumsri's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Chumsri to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chumsri practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chumsri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chumsri is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Chumsri's licenses on file in 4 states: Florida, South Carolina, Maryland and Pennsylvania.

Dmand AI lists breast cancer, chronic leukemia, lymphoma and prostate cancer among the conditions Dr. Chumsri treats.

CMS data shows 577 Medicare services from Dr. Chumsri across 12 procedure codes in 2024, for 235 Medicare patients. Medicare paid $32,236 for them. Every service was in an office.

CMS counts 235 Medicare patients who saw Dr. Chumsri in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have cancer, and 73% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chumsri's median patient age at 60, with 91% women.

In 2024, Dr. Chumsri wrote 820 Medicare Part D claims for 188 patients. 81% of them were for generic drugs. CMS names the drug for 603 of them, across 19 drugs with 11 or more claims each, at $1,589,834 in total drug cost. In 2023, CMS named 645 claims across 15 drugs.

Dr. Chumsri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chumsri as offering telehealth.

Dmand AI links 91 papers to Dr. Chumsri, published from 2007 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Breast Neoplasms, Receptor, ErbB-2 and Antineoplastic Combined Chemotherapy Protocols. Dr. Chumsri has published most often in Clin Cancer Res. Dr. Chumsri's most frequent co-authors are Alvaro Moreno-Aspitia, MD, Pooja Prem Advani, MD and Edith Perez, MD.

Dmand AI links Dr. Chumsri to 16 clinical trials, 6 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Triple Negative Breast Neoplasms and Breast Diseases. Mayo Clinic sponsors the most, 8.

CMS Open Payments shows 76 general payments to Dr. Chumsri from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Merck Sharp & Dohme Corporation paid the most, $8,319. It also lists 9 research payments totaling $225,787 from 2017 to 2021.

Dmand AI lists 12 awards for Dr. Chumsri, most recently Outstanding Research Award in 2019. Dr. Chumsri serves on Mayo Clinic Florida Clinical Trials Leadership Council, Mayo Clinic Florida Fellowship Program Education Committee and ACCRU Consortium Breast Cancer Committee.

Dr. Chumsri graduated from Chulalongkorn University Faculty of Medicine in 1999. Dr. Chumsri is a member of AACR and ASCO.

Dr. Chumsri is in network with 9 carriers, including Excellus BlueCross BlueShield, Elevance and United Healthcare. POS plans come from the most carriers, 5. Check the plan with the practice before a visit.